Marzena Flasza-Baron

Business Development Manager at CGT Catapult

Speaker

Marzena Flasza-Baron holds a position of Business Development Accounts Manager at the Cell and Gene Therapy Catapult and is responsible for overseeing business development activities in her EU and USA territories, aimed at supporting foreign academics and companies in cell and gene therapy developments and commercialisation. Marzena is responsible for securing business from her international territories through commercial contracts or via forming bilateral or multi-party collaborations involving international partners. Marzena is working with Head of Transactions to deliver the CGT Catapult international engagement strategy and to establish and maintain collaborations with academics and industry partners from outside of the UK.

During her career to date, Marzena has gained her PhD in biology and worked for 13 years in cell therapeutics/regenerative medicine field both in biotech and academic settings. She researched the process of reprogramming of differentiated cells to state of pluripotency and created iPSC lines. She also led R&D team developing process of GMP manufacture of skin tissue replacement product composed of auto-synthetised collagen matrix and living human skin derived cells for treatment of trauma wounds and burns. Before taking up role at Cell and Gene Therapy Catapult, she held role of business development and transactions at contract research organisation focusing on in vitro and in vivo disease modelling across many therapeutic areas including wound healing, cancer and immune inflammation.